Clinical trial
Magnetic Resonance Spectroscopy to Evaluate Tourette s Syndrome
NCT00030953 · National Institute of Neurological Disorders and Stroke (NINDS), NIH · Completed
Key facts
| NCT number | NCT00030953 |
|---|---|
| Title | Magnetic Resonance Spectroscopy to Evaluate Tourette s Syndrome |
| Official title | Evaluation of Tourette's Syndrome With Multimetabolite H-Magnetic Resonance Spectroscopy at 3T |
| Lead sponsor | National Institute of Neurological Disorders and Stroke (NINDS), NIH |
| Status | Completed |
| Study type | Observational |
| Conditions | Tourette Syndrome |
| Enrollment | 100 |
| Start date | Feb 11, 2002 |
| Completion | Feb 3, 2015 |
| First posted | Feb 15, 2002 |
| Last update posted | Dec 17, 2019 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: